文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

脓毒症合并急性肾损伤患者持续肾脏替代治疗后的死亡危险因素:多中心观察性研究的二次分析

[Risk factors for mortality in intensive care unit patients with sepsis combined with acute kidney injury after continuous renal replacement therapy: secondary analysis of the data from a multicenter observational study].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2019-01-01
一句话结论在ICU脓毒症合并AKI接受CRRT的患者中,年龄、APACHE II评分、SOFA评分和心功能IV级是死亡的独立危险因素。

该研究为对BAKIT研究(2012年3月1日至8月31日北京28家医院30个ICU的前瞻性观察性AKI流行病学研究)数据的二次分析,纳入189例脓毒症合并AKI并接受CRRT的ICU患者,ICU死亡率为54.50%(103例死亡)。单因素分析显示死亡组年龄更大、APACHE II和SOFA评分更高、平均动脉压最低值更低、心功能IV级/高血压/冠心病/慢性肾脏病合并比例更高、因高钾血症和严重代谢性酸中毒接受CRRT比例更高。多因素Logistic回归显示年龄、APACHE II、SOFA和心功能IV级为独立危险因素。该结果有助于在床旁识别CRRT脓毒症合并AKI患者中的高危人群。

要点

  • 189例脓毒症合并AKI接受CRRT的ICU患者中103例死亡,ICU死亡率54.50%。
  • 多因素分析显示年龄为独立危险因素:OR=1.054,95%CI 1.032-1.077,P<0.001。
  • APACHE II评分越高死亡风险越高:OR=1.061,95%CI 1.021-1.102,P=0.034。
  • SOFA评分越高死亡风险越高:OR=1.078,95%CI 1.033-1.116,P=0.042。
  • 心功能IV级为独立危险因素:OR=3.357,95%CI 0.884-12.747,P=0.045。

适用人群与场景

  • 2012年3月1日至8月31日BAKIT研究中北京28家医院30个ICU的脓毒症合并AKI并接受CRRT治疗的ICU患者,共189例。

诊断标准与关键阈值

  • APACHE II与SOFA评分采用入ICU 24小时内指标最差值计算。
  • 观察终点为ICU死亡。

研究设计与关键结果

  • 研究类型:多中心前瞻性观察性研究(BAKIT研究)数据的二次分析,纳入189例脓毒症合并AKI接受CRRT的ICU患者,103例死亡,ICU死亡率54.50%。
  • 死亡组与生存组比较:年龄更大多(岁:77(67,83)vs. 58(39,73)),因呼吸系统疾病入ICU比例更高(55.40% vs. 38.37%),合并心功能IV级比例更高(20.39% vs. 3.49%),合并高血压比例更高(53.40% vs. 34.88%),合并冠心病比例更高(40.78% vs. 10.47%),合并慢性肾脏病(伴肾功能不全)比例更高(20.39% vs. 9.30%),APACHE II评分更高(27.53±8.59 vs. 22.73±8.36),SOFA评分更高(12.22±4.00 vs. 9.51±4.49),平均动脉压最低值更低(mmHg:65.36±19.52 vs. 71.60±17.92),有创机械通气比例更高(80.58% vs. 65.12%),因高钾血症接受CRRT比例更高(28.16% vs. 9.30%),因严重代谢性酸中毒接受
  • 多因素Logistic回归显示年龄、APACHE II、SOFA、平均动脉压、心功能IV级、冠心病和高钾血症为死亡危险因素;年龄、APACHE II、SOFA和心功能IV级为独立危险因素(年龄:OR=1.054,95%CI 1.032-1.077,P<0.001;APACHE II:OR=1.061,95%CI 1.021-1.102,P=0.034;SOFA:OR=1.078,95%CI 1.033-1.116,P=0.042;心功能IV级:OR=3.357,95%CI 0.884-12.747,P=0.045)。

证据类型、等级与局限

  • 证据类型:多中心前瞻性观察性研究(BAKIT研究)数据的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于ICU脓毒症合并AKI并接受CRRT的患者,年龄、APACHE II评分、SOFA评分和心功能IV级可帮助识别ICU死亡高危人群。
  • 原文未据此给出推荐。

指南或共识出处

  • BAKIT研究:北京28家医院30个ICU的AKI流行病学前瞻性观察性研究,中国临床试验注册号ChiCTR-ONC-11001875。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To analyze the risk factors of death in intensive care unit (ICU) patients with sepsis and acute kidney injury (AKI) undergoing continuous renal replacement therapy (CRRT).

METHODS: The data of patients with sepsis complicated with AKI who received CRRT treatment from March 1st to August 31st in 2012 in BAKIT study (a prospective observational study of AKI epidemiology in 30 ICUs of 28 hospitals in Beijing) were re-analyzed. The demographic data, clinical and laboratory data of patients were collected, including gender, age, case source, body mass index (BMI), blood pressure, the length of ICU stay, complications, other organs' function, drug use, CRRT, mechanical ventilation and vasoactive drugs. Acute physiology and chronic health evaluation II (APACHE II) and sequential organ failure score (SOFA) were calculated by the worst value of the index within 24 hours of entry into ICU. The end point of observation was to ICU mortality. All test factors were analyzed by single factor analysis, and then multivariate Logistic regression analysis was carried out for the parameters with statistical significance in single factor analysis. Risk factors affecting CRRT in ICU sepsis patients with AKI were screened.

RESULTS: A total of 189 patients were enrolled, 103 of whom died, with a mortality rate of 54.50%. Compared with the survival group, the death group had an older age [years old: 77(67, 83) vs. 58 (39, 73)], a higher proportion of ICU entry due to respiratory diseases (55.40% vs. 38.37%), a higher proportion of complications such as grade IV of cardiac function, hypertension, coronary heart disease, chronic kidney disease (with renal insufficiency; 20.39% vs. 3.49%, 53.40% vs. 34.88%, 40.78% vs.10.47%, 20.39% vs. 9.30%, respectively), a longer the length of ICU stay [days: 8 (5, 19) vs. 13 (7, 22)], a higher APACHE II and SOFA scores (27.53±8.59 vs. 22.73±8.36, 12.22±4.00 vs. 9.51±4.49), a lower mean arterial pressure (MAP) valley value [mmHg (1 mmHg = 0.133 kPa): 65.36±19.52 vs. 71.60±17.92], a higher proportion of invasive mechanical ventilation (80.58% vs. 65.12%), high proportion of CRRT treatment due to hyperkalemia and severe metabolic acidosis (28.16% vs. 9.30%, 63.11% vs. 22.09%), and the time from ICU entry to CRRT initiation was longer [days: 1 (0, 5) vs. 1 (0, 2)], which differences were statistically significant (all P < 0.05). Logistic regression analysis showed that age, APACHE II, SOFA, MAP, grade IV of cardiac function, coronary heart disease and hyperkalemia were risk factors for death in ICU sepsis patients with AKI treated by CRRT. Age, APACHE II, SOFA and grade IV of cardiac function were independent risk factors [age: odds ratio (OR) = 1.054, 95% confidence interval (95%CI) = 1.032-1.077, P < 0.001; APACHE II: OR = 1.061, 95%CI = 1.021-1.102, P = 0.034; SOFA: OR = 1.078, 95%CI = 1.033-1.116, P = 0.042; grade IV of cardiac function: OR = 3.357, 95%CI = 0.884-12.747, P = 0.045].

CONCLUSIONS: Age, APACHE II, SOAF and grade IV of cardiac function were independent risk factors for death in ICU sepsis patients with AKI treated with CRRT.

TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR-ONC-11001875.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhang Q, Fei Y, Jiang L, et al. [Risk factors for mortality in intensive care unit patients with sepsis combined with acute kidney injury after continuous renal replacement therapy: secondary analysis of the data from a multicenter observational study]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 30827301. doi:10.3760/cma.j.issn.2095-4352.2019.02.007

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。